• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    1.52 Up 0.02(1.33%) Feb 9, 4:00PM EST
    Prev Close:1.50
    Open:1.49
    Bid:1.00 x 300
    Ask:2.78 x 300
    1y Target Est:5.50
    Beta:0.984398
    Earnings Date:Feb 29 - Mar 4 (Est.)
    Day's Range:1.44 - 1.59
    52wk Range:1.30 - 5.12
    Volume:1,778,273
    Avg Vol (3m):2,888,920
    Market Cap:368.68M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNAUp 1.33%368.68M
    OREXDown 7.47%234.16M
    GSKDown 0.33%95.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Dec-15) :-0.13
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback